Assertio Holdings, Inc. Contracts & Agreements

35 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Annual Bonus Plan
Bonus & Incentive Agreements
Assertio Holdings, Inc.
2024
Third Amendment to Supply Agreement, dated as of April 12, 2023, by and between Spectrum and Hanmi Pharmaceuticals Co., Ltd
Supply Agreements
Assertio Holdings, Inc.
2024
Letter agreement, dated as of February 1, 2024, between Spectrum and Hanmi Pharmaceuticals Co., Ltd
Assertio Holdings, Inc.
2024
Offer Letter dated January 2, 2024 between the Company and Heather Mason
Assertio Holdings, Inc.
2024
Contingent Value Rights Agreement, dated as of July 31, 2023, entered into by and between the Company and Computershare Inc. and its affiliate Computershare Trust Company, N.A.,...
Assertio Holdings, Inc.
2023
Assertio Holdings, Inc. Amended and Restated 2014 Omnibus Incentive Plan, As Amended
Bonus & Incentive Agreements
Assertio Holdings, Inc.
2023
Agreement and Plan of Merger, dated April 24, 2023, by and among Assertio Holdings, Inc., Spade Merger Sub 1, Inc. and Spectrum Pharmaceuticals, Inc. (Form of CVR Agreement...
Merger Agreements
Assertio Holdings, Inc.
2023
Form of Equity Award Documents under Amended and Restated 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Assertio Holdings, Inc.
2023
Form of Equity Award Documents for Inducement Grants
Assertio Holdings, Inc.
Pharmaceuticals
2023
Amended and Restated Annual Bonus Plan
Bonus & Incentive Agreements
Assertio Holdings, Inc.
2023
NonEmployee Director Compensation and Grant Policy
Compensation Agreements
Assertio Holdings, Inc.
2023
Form of Exchange Agreement
Exchange Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2023
Indenture, dated as of August 25, 2022, between Assertio Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2022
Sales Agreement, dated as of December 17, 2021, by and between the Company and Roth Capital Partners, LLC
Sales Agreements
Assertio Holdings, Inc.
2022
Asset Purchase Agreement, dated as of December 15, 2021, by and among Otter Pharmaceuticals, LLC, Antares Pharma, Inc. and the Company
Purchase Agreements
Assertio Holdings, Inc.
2022
Second Supplemental Indenture, dated as of December 15, 2021, by and among Otter Pharmaceuticals, LLC, the Company, the existing guarantors and Wilmington Savings Fund Society
Indenture Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2022
Form of Management Continuity Agreement
Management Agreements
Assertio Holdings, Inc.
2022
Amended and Restated Annual Bonus Plan
Bonus & Incentive Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2022
Separation Agreement and Release of Claims between Todd N. Smith and Assertio Management, LLC, dated December 14, 2020 (incorporated by reference to Exhibit 10.14 to the Companys...
Separation Agreements
Assertio Holdings, Inc.
2022
Separation Agreement and Release of Claims between Mark Strobeck and Assertio Management, LLC, dated December 14, 2020 (incorporated by reference to Exhibit 10.15 to the Companys...
Separation Agreements
Assertio Holdings, Inc.
2022
Amendment No. 3 to Collaborative License, Exclusive Manufacture and Global Supply Agreement between Zyla Life Sciences and Cosette Pharmaceuticals, Inc. effective July 9, 2021
License Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2021
Separation Agreement and Release of Claims between Todd N. Smith and Assertio Management, LLC, dated December 14, 2020
Separation Agreements
Assertio Holdings, Inc.
2021
Separation Agreement and Release of Claims between Mark Strobeck and Assertio Management, LLC, dated December 14, 2020
Separation Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2021
Securities Purchase Agreement by and among the Company and certain investors, dated as of February 10, 2021
Purchase Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2021
Placement Agency Agreement by and between the Company and Roth Capital Partners, LLC, dated as of February 10, 2021
Agency Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2021
Securities Purchase Agreement by and among the Company and certain investors, dated as of February 5, 2021
Purchase Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2021
Placement Agency Agreement by and between the Company and Roth Capital Partners, LLC, dated as of February 5, 2021
Agency Agreements
Assertio Holdings, Inc.
2021
Registration Rights Agreement between the Company and Loan Security Holdings I LLC, dated May 20, 2020
Loan Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2020
Form of Warrant
Warrant Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2020
Employment Agreement between Zyla Life Sciences and Todd N. Smith, dated June 17, 2020
Employment Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2020
Offer Letter, dated June 23, 2020, between Zyla Life Sciences and Mark Strobeck, Ph.D
Assertio Holdings, Inc.
2020
Offer Letter, dated June 23, 2020, between Zyla Life Sciences and Megan C. Timmins
Assertio Holdings, Inc.
2020
Form of Management Continuity Agreement, dated June 23, 2020, between Zyla Life Sciences and Zyla Life Sciences executive officers
Management Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2020
Transition and Consulting Agreement, dated June
Consulting Agreements
Assertio Holdings, Inc.
Pharmaceuticals
IL
2020
Supplemental Indenture by and among Assertio Holdings and Wilmington Savings Fund Society dated as of May 20, 2020
Indenture Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2020